VERVE THERAPEUTICS INC shareholders Q3 2023

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

VERVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 48,800$647,0880.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 33,127$439,2640.00%
SIGNATUREFD, LLC 47$6230.00%
Covestor Ltd 7$00.00%
MASSMUTUAL TRUST CO FSB/ADV 22$2920.00%
Mitsubishi UFJ Asset Management Co., Ltd. 16,479$218,5120.00%
UBS Group AG 83,263$1,104,0670.00%
VOYA INVESTMENT MANAGEMENT LLC 20,397$270,4640.00%
Daiwa Securities Group Inc. 5,013$660.00%
Capital Advisors, Ltd. LLC 31$00.00%
JANE STREET GROUP, LLC 19,785$262,3490.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 24,852$329,5380.00%
LAZARD ASSET MANAGEMENT LLC 2,015$260.00%
GROUP ONE TRADING, L.P. 1,353$17,9410.00%
Legal & General Group Plc 38,850$515,1510.00%
AMERICAN CENTURY COMPANIES INC 26,830$355,7660.00%
WELLS FARGO & COMPANY/MN 63,785$845,7900.00%
BANK OF AMERICA CORP /DE/ 314,772$4,173,8760.00%
McIlrath & Eck, LLC 75$9950.00%
External links

This page lists VERVE THERAPEUTICS INC's shareholders in Q3 2023. To view VERVE THERAPEUTICS INC's shareholder history, click here.